Drug delivery Archives

In Depth 2 Dec 2024

The rise of cancer vaccines: A new era in immunotherapy

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors.

December 2, 2024 - 8 minutesmins - By Jules Adam

Unlocking AAV gene therapy potential: The role of successful characterization

Explore the role and challenges of AAV characterization, the significance of capsid filling, and the best methods to enhance gene therapy.

November 5, 2024 - 8 minutesmins - By Ute Boronowsky

Best in Biotech 22 Oct 2024

Eight nanotechnology companies to watch out for

Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.

October 22, 2024 - 10 minutesmins - By Roohi Mariam Peter

Sublingual delivery of GLP-1 receptor agonists

Sublingual delivery: the future for GLP-1 receptor agonists

Discover how GLP-1 receptor agonists, now thriving in obesity treatment, could benefit from a more patient-friendly sublingual delivery method.

October 1, 2024 - 7 minutesmins - By External Contributor

In Depth 25 Sep 2024

How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market

Discover an untold biotech story and find out how Pfizer missed an opportunity in the GLP-1 market because of an exit in the ’90s.

September 25, 2024 - 9 minutesmins - By Jennifer Tsang

News and Trends 16 Sep 2024

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

Delve into Vironexis’ launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.

September 16, 2024 - 6 minutesmins - By Jules Adam

Best in Biotech 23 Apr 2024

Eight biotechnology companies leading the charge in Poland

Discover eight biotech companies at the forefront of Poland’s emerging biotech sector, which is becoming a hotspot for startups.

April 23, 2024 - 7 minutesmins - By Jules Adam

In Depth 17 Jan 2024

Bladder cancer treatment: where are we standing?

Bladder cancer is the 10th most common cancer. Delve into the most promising strides in bladder cancer treatment.

January 17, 2024 - 8 minutesmins - By Jules Adam

News and Trends 11 Jul 2023

Inhaled mRNA medicines redefine respiratory disease treatment

By Carsten Rudolph, co-founder and CEO of Ethris Advancements in mRNA technology have led to the development of inhaled mRNA medicines, which hold tremendous potential for revolutionizing the treatment of respiratory diseases, an area with high unmet needs. However, the primary hurdle in its clinical application lies in the identification of a delivery system that […]

July 11, 2023 - 3 minutesmins - By External Contributor

News and Trends 10 May 2023

Delivering on the need for vector innovation in genetic medicine

By Tuyen Ong, CEO Ring Therapeutics, CEO-Partner Flagship Pioneering Gene therapy is a life-changing class of medicine that can treat patients with once intractable diseases. While revolutionary, significant limitations remain for the vectors that carry them. Viruses are masters at delivering genetic material to the nucleus of the organisms they infect, and because of this, […]

May 10, 2023 - 2 minutesmins - By External Contributor

News and Trends 9 May 2023

Researchers overcome stem cell delivery issues

A recent study explains how researchers have devised a new method for delivering particles into stem cells, which are difficult to penetrate. The discovery will make it easier to direct and enhance the processes involved in regenerative medicine. Regenerative medicine takes advantage of the fact that our body’s stem cells can change into many other […]

May 9, 2023 - 5 minutesmins - By Jim Cornall

News and Trends 11 Apr 2023

Intracellular drug delivery startup Vitarka Therapeutics raises £1.27M

Vitarka Therapeutics, which focuses on non-viral drug delivery technology, has raised £1.27 million ($1.58 million) in equity from venture capital firm SOSV, the UK Innovation & Science Seed Fund (UK12S) and grant funding from Innovate UK. Founded in 2021 by Vineeta Tripathi, Vitarka Therapeutics is developing combination medicines using RNAi therapies and a non-viral drug […]

April 11, 2023 - 2 minutesmins - By Jim Cornall

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Drug delivery

The rise of cancer vaccines: A new era in immunotherapy

Unlocking AAV gene therapy potential: The role of successful characterization

Eight nanotechnology companies to watch out for

Sublingual delivery: the future for GLP-1 receptor agonists

How Pfizer’s decision in the ’90s cost them a stronghold in the GLP-1 market

Vironexis’ AAV vector approach: The next frontier in cancer immunology?

Eight biotechnology companies leading the charge in Poland

Bladder cancer treatment: where are we standing?

Inhaled mRNA medicines redefine respiratory disease treatment

Delivering on the need for vector innovation in genetic medicine

Researchers overcome stem cell delivery issues

Intracellular drug delivery startup Vitarka Therapeutics raises £1.27M

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!